Booster Doses and Prioritizing Lives Saved.
作者信息
Patel Minal K
机构信息
From the COVID-19 Response International Task Force, Centers for Disease Control and Prevention, Atlanta.
出版信息
N Engl J Med. 2021 Dec 23;385(26):2476-2477. doi: 10.1056/NEJMe2117592. Epub 2021 Dec 8.
Abstract
摘要
相似文献
1
Booster Doses and Prioritizing Lives Saved.加强剂量与拯救生命的优先级
N Engl J Med. 2021 Dec 23;385(26):2476-2477. doi: 10.1056/NEJMe2117592. Epub 2021 Dec 8.
2
Implications of suboptimal COVID-19 vaccination coverage in Florida and Texas.佛罗里达州和得克萨斯州新冠疫苗接种率未达最佳水平的影响。
Lancet Infect Dis. 2021 Nov;21(11):1493-1494. doi: 10.1016/S1473-3099(21)00620-4. Epub 2021 Oct 7.
3
Intervention heroes of Mozambique from 1997 to 2015: estimates of maternal and child lives saved using the Lives Saved Tool.1997 年至 2015 年莫桑比克的干预措施英雄：使用拯救生命工具估计挽救的母婴生命数。
J Glob Health. 2018 Dec;8(2):021202. doi: 10.7189/jogh.08.021201.
4
Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December, 2020, to March, 2023: a retrospective surveillance study.2020 年 12 月至 2023 年 3 月期间，世界卫生组织欧洲区域内由 COVID-19 疫苗接种项目直接挽救的生命估计数：一项回顾性监测研究。
Lancet Respir Med. 2024 Sep;12(9):714-727. doi: 10.1016/S2213-2600(24)00179-6. Epub 2024 Aug 7.
5
Projecting the lives saved by continuing the historical scale-up of child and maternal health interventions in Mozambique until 2030.预测在 2030 年之前继续扩大莫桑比克儿童和孕产妇健康干预措施的历史规模所带来的生命拯救。
J Glob Health. 2019 Jun;9(1):011102. doi: 10.7189/jogh.09.011102.
6
Vaccinating the oldest against COVID-19 saves both the most lives and most years of life.为最年长的人群接种 COVID-19 疫苗可挽救最多的生命和最长的预期寿命。
Proc Natl Acad Sci U S A. 2021 Mar 16;118(11). doi: 10.1073/pnas.2026322118.
7
COVID-19 Australia: Epidemiology Report 38 Reporting period ending 28 March 2021.澳大利亚2019冠状病毒病：流行病学报告38 报告期截至2021年3月28日。
Commun Dis Intell (2018). 2021 Apr 9;45. doi: 10.33321/cdi.2021.45.19.
8
COVID-19 vaccine intentions in Australia.澳大利亚的新冠疫苗接种意向。
Lancet Infect Dis. 2021 Dec;21(12):1628-1629. doi: 10.1016/S1473-3099(21)00694-0.
9
Contribution of child health interventions to under-five mortality decline in Ghana: A modeling study using lives saved and missed opportunity tools.儿童健康干预措施对加纳五岁以下儿童死亡率下降的贡献：使用挽救生命和错失机会工具的建模研究。
PLoS One. 2022 Aug 1;17(8):e0267776. doi: 10.1371/journal.pone.0267776. eCollection 2022.
10
Evidence of Impact: iCCM as a strategy to save lives of children under five.影响证据：整合儿童社区管理作为挽救 5 岁以下儿童生命的策略。
J Glob Health. 2019 Jun;9(1):010801. doi: 10.7189/jogh.09.010801.
引用本文的文献
1
Modeling and predicting individual variation in COVID-19 vaccine-elicited antibody response in the general population.模拟和预测普通人群中COVID-19疫苗引发的抗体反应的个体差异。
PLOS Digit Health. 2024 May 3;3(5):e0000497. doi: 10.1371/journal.pdig.0000497. eCollection 2024 May.
2
The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的德尔塔和奥密克戎变体：我们目前所了解的情况。
Vaccines (Basel). 2022 Nov 14;10(11):1926. doi: 10.3390/vaccines10111926.
3
Multilevel determinants on COVID-19 booster intention among Americans.美国人对 COVID-19 加强针意愿的多层次决定因素。
Prev Med. 2022 Nov;164:107269. doi: 10.1016/j.ypmed.2022.107269. Epub 2022 Sep 23.
4
Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up.在比利时初级保健提供者中针对 SARS-CoV-2 的抗体的流行率、发生率和持久性：一项前瞻性队列研究，随访 12 个月。
BMJ Open. 2022 Sep 19;12(9):e065897. doi: 10.1136/bmjopen-2022-065897.
5
Rapid Evaluation of Vaccine Booster Effectiveness against SARS-CoV-2 Variants.快速评估疫苗对 SARS-CoV-2 变异株的加强针效力。
Microbiol Spectr. 2022 Oct 26;10(5):e0225722. doi: 10.1128/spectrum.02257-22. Epub 2022 Sep 7.
6
Non-Arteritic Anterior Ischemic Optic Neuropathy Following COVID-19 Vaccination.新冠疫苗接种后非动脉炎性前部缺血性视神经病变
Vaccines (Basel). 2022 Jun 10;10(6):931. doi: 10.3390/vaccines10060931.
7
A Calculator for COVID-19 Severity Prediction Based on Patient Risk Factors and Number of Vaccines Received.基于患者风险因素和接种疫苗数量的新冠肺炎严重程度预测计算器。
Microorganisms. 2022 Jun 16;10(6):1238. doi: 10.3390/microorganisms10061238.
8
Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study.短期来看，以色列 60 岁及以上人群中，4 剂与 3 剂 BNT162b2 疫苗的相对有效性：回顾性、阴性检测、病例对照研究。
BMJ. 2022 May 24;377:e071113. doi: 10.1136/bmj-2022-071113.
9
Vaccination against SARS-CoV-2 infection among vulnerable and marginalised population groups in Denmark: A nationwide population-based study.丹麦弱势群体和边缘化人群中针对严重急性呼吸综合征冠状病毒2感染的疫苗接种：一项基于全国人口的研究。
Lancet Reg Health Eur. 2022 Mar 25;16:100355. doi: 10.1016/j.lanepe.2022.100355. eCollection 2022 May.
10
Predicting COVID-19 severity using major risk factors and received vaccines.利用主要风险因素和接种疫苗情况预测新冠病毒疾病的严重程度。
medRxiv. 2022 Jan 3:2021.12.31.21268575. doi: 10.1101/2021.12.31.21268575.
本文引用的文献
1
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.疫苗预防严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）感染和 COVID-19 疾病有效性的持续时间：系统评价和荟萃回归的结果。
Lancet. 2022 Mar 5;399(10328):924-944. doi: 10.1016/S0140-6736(22)00152-0. Epub 2022 Feb 23.
2
BNT162b2 Vaccine Booster and Mortality Due to Covid-19.BNT162b2 疫苗加强针与新冠病毒导致的死亡率。
N Engl J Med. 2021 Dec 23;385(26):2413-2420. doi: 10.1056/NEJMoa2115624. Epub 2021 Dec 8.
3
Protection against Covid-19 by BNT162b2 Booster across Age Groups.辉瑞-BioNTech 疫苗加强针在各年龄段对预防新冠病毒的保护作用
N Engl J Med. 2021 Dec 23;385(26):2421-2430. doi: 10.1056/NEJMoa2115926. Epub 2021 Dec 8.
4
Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data.估计美国 COVID-19 疫苗接种计划对 65 岁及以上成年人 COVID-19 病例、急诊就诊、住院和死亡的早期影响：国家监测数据的生态分析。
Lancet. 2022 Jan 8;399(10320):152-160. doi: 10.1016/S0140-6736(21)02226-1. Epub 2021 Nov 3.
5
A global database of COVID-19 vaccinations.一个全球 COVID-19 疫苗接种数据库。
Nat Hum Behav. 2021 Jul;5(7):947-953. doi: 10.1038/s41562-021-01122-8. Epub 2021 May 10.
Zotero 插件